Combination Therapies in Relapsed/Refractory AML | Aplastic Anemia & MDS International Foundation Return to top.

Combination Therapies in Relapsed/Refractory AML

Registration for this Webinar is now open. Please use the form below to register and receive a link to watch live on May 12, 2021.

Bone Marrow Transplant
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presentation Date: 
Wed, 05/12/2021 - 2:30pm (EDT)


Dr. Ivana Gojo, Associate Professor of Oncology at Johns Hopkins Medicine, will discuss the current treatment options for patients with relapsed/refractory AML as well as some of the most promising treatment options that are in clinical trial. Dr. Gojo will answer patient questions during the last 15 minutes of the presentation.

Share with